69 related articles for article (PubMed ID: 12532331)
1. The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein.
Strachan GD; Jordan-Sciutto KL; Rallapalli R; Tuan RS; Hall DJ
J Cell Biochem; 2003 Feb; 88(3):557-68. PubMed ID: 12532331
[TBL] [Abstract][Full Text] [Related]
2. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation.
Kong HJ; Yu HJ; Hong S; Park MJ; Choi YH; An WG; Lee JW; Cheong J
Mol Cancer Res; 2003 Nov; 1(13):948-58. PubMed ID: 14638867
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
Rubin SM; Gall AL; Zheng N; Pavletich NP
Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the Arabidopsis E2F and DP proteins confers their concomitant nuclear translocation and transactivation.
Kosugi S; Ohashi Y
Plant Physiol; 2002 Mar; 128(3):833-43. PubMed ID: 11891240
[TBL] [Abstract][Full Text] [Related]
5. NPDC-1, a regulator of neural cell proliferation and differentiation, interacts with E2F-1, reduces its binding to DNA and modulates its transcriptional activity.
Sansal I; Dupont E; Toru D; Evrard C; Rouget P
Oncogene; 2000 Oct; 19(43):5000-9. PubMed ID: 11042687
[TBL] [Abstract][Full Text] [Related]
6. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes.
Korenjak M; Taylor-Harding B; Binné UK; Satterlee JS; Stevaux O; Aasland R; White-Cooper H; Dyson N; Brehm A
Cell; 2004 Oct; 119(2):181-93. PubMed ID: 15479636
[TBL] [Abstract][Full Text] [Related]
7. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
8. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
9. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.
Di Stefano L; Jensen MR; Helin K
EMBO J; 2003 Dec; 22(23):6289-98. PubMed ID: 14633988
[TBL] [Abstract][Full Text] [Related]
10. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
Nip J; Strom DK; Eischen CM; Cleveland JL; Zambetti GP; Hiebert SW
Oncogene; 2001 Feb; 20(8):910-20. PubMed ID: 11314026
[TBL] [Abstract][Full Text] [Related]
11. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
12. A transcriptionally inactive E2F-1 targets the MDM family of proteins for proteolytic degradation.
Strachan GD; Rallapalli R; Pucci B; Lafond TP; Hall DJ
J Biol Chem; 2001 Dec; 276(49):45677-85. PubMed ID: 11568180
[TBL] [Abstract][Full Text] [Related]
13. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
14. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
15. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.
Yoshida K; Inoue I
Oncogene; 2004 Aug; 23(37):6250-60. PubMed ID: 15195143
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
18. ASPP1 and ASPP2 are new transcriptional targets of E2F.
Fogal V; Kartasheva NN; Trigiante G; Llanos S; Yap D; Vousden KH; Lu X
Cell Death Differ; 2005 Apr; 12(4):369-76. PubMed ID: 15731768
[TBL] [Abstract][Full Text] [Related]
19. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
20. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
